39 results
UPLOAD
CNTB
Connect Biopharma Holdings Ltd
11 Jul 23
Letter from SEC
12:00am
describe any additional materials
that were reviewed
and tell us whether you relied upon any legal opinions or third-party
certifications … such as
affidavits as the basis for your submission. In your response, please
provide a similarly
detailed discussion of the materials
F-1
EX-10.15
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
and other intellectual property rights in all Inventions, works and materials made, originated, developed, written or prepared by you (whether alone … unconditionally and irrevocably agree to waive any and all moral rights you may have as an author, designer or inventor of any such works or materials under
CORRESP
CNTB
Connect Biopharma Holdings Ltd
24 Jul 23
Correspondence with SEC
12:00am
with your required submission under paragraph (a). Please supplementally describe any additional materials that were reviewed and tell us whether you … a similarly detailed discussion of the materials reviewed and legal opinions or third-party certifications relied upon in connection with the required
F-1
EX-10.13
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
) Party B shall guarantee the authenticity of the contents of all materials that it has provided at the time of applying for employment. If Party A finds … that Party B has provided false application materials within the term of the employment contract, Party A shall have the right to terminate
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
on the packaging after considering Licensor’s request in good faith. [***]
5.5. Promotional Materials. Licensee is responsible for and has the sole … decision authority in creating, developing, producing, or otherwise obtaining and utilizing sales and marketing materials (including without limitation
DRSLTR
c4x4wsp
26 Jan 21
Correspondence regarding draft registration statement
12:00am
6-K
wlpblnh4g7ut11sje5
16 Feb 22
Current report (foreign)
4:01pm
6-K
xilbf6xa9sy
22 Nov 21
Current report (foreign)
5:12pm
F-1/A
EX-99.1
8hl8chq
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
6-K
p53i04m 9mo
10 Jun 22
Current report (foreign)
6:05am
20-F
EX-4.13
l0vg684kq0ywwsm2
31 Mar 22
Annual report (foreign)
4:33pm
20-F
x4onoqyd
31 Mar 22
Annual report (foreign)
4:33pm
F-1/A
EX-1.1
2rce08rvpul85i2w5
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
20-F
EX-2.5
yufige
31 Mar 22
Annual report (foreign)
4:33pm
DRS/A
pvnbq
26 Jan 21
Draft registration statement (amended)
12:00am
F-1/A
kdsqc9qet90td4ac1xc
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
cerfnh8
18 Mar 21
Registration statement (foreign) (amended)
6:15am
424B4
kfiba awi20l
19 Mar 21
Prospectus supplement with pricing info
4:49pm